Daniel Vitt
Chief Executive Officer at IMMUNIC, INC.
Net worth: 474 865 $ as of 2024-04-29
Daniel Vitt active positions
Companies | Position | Start | End |
---|---|---|---|
IMMUNIC, INC. | Director/Board Member | 2018-12-31 | - |
Chief Executive Officer | 2016-12-31 | - | |
President | 2016-12-31 | - | |
Weltoffen-Germering Weltladen eG | Director/Board Member | 2010-05-09 | - |
4SC Discovery GmbH
4SC Discovery GmbH BiotechnologyHealth Technology 4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany. | Chief Tech/Sci/R&D Officer | 2011-12-31 | - |
Chief Executive Officer | 2011-12-31 | - | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Director/Board Member | - | - |
Chief Executive Officer | 2017-01-08 | - | |
President | - | - | |
quattro research GmbH
quattro research GmbH Miscellaneous Commercial ServicesCommercial Services Quattro Research GmbH is an interdisciplinary team of scientists and IT professionals that provides IT solutions for research and development. The private company is based in Martinsried, Germany. The German company specializes in bioregistration and handles antibodies and other macromolecules. The company also offers products such as the HELM hierarchical editing language for macromolecules and an electronic lab journal. Quattro/CM is their software that helps manage inventory easily. | Director/Board Member | - | - |
Immunic Research GmbH | Chief Executive Officer | - | - |
Brauhaus Germering GmbH | Chief Executive Officer | 2017-12-31 | - |
Founder | 2017-12-31 | - | |
Listrax Ug | Chief Executive Officer | - | - |
Career history of Daniel Vitt
Former positions of Daniel Vitt
Companies | Position | Start | End |
---|---|---|---|
4SC AG | Chief Tech/Sci/R&D Officer | 2010-05-09 | 2016-12-30 |
Founder | 1996-12-31 | 2016-12-30 | |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Daniel Vitt
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Statistics
International
Germany | 11 |
United States | 3 |
Operational
Chief Executive Officer | 7 |
Director/Board Member | 6 |
President | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
4SC AG | Health Technology |
IMMUNIC, INC. | Health Technology |
Private companies | 9 |
---|---|
Weltoffen-Germering Weltladen eG | |
4SC Discovery GmbH
4SC Discovery GmbH BiotechnologyHealth Technology 4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany. | Health Technology |
Nexigen GmbH
Nexigen GmbH Pharmaceuticals: MajorHealth Technology Nexigen GmbH identifies and develops peptide based therapeutics for cancer. It focuses on the development of pathways to create transformative cancer therapies. The firm's technologies give access to drug targets which pose significant challenges to conventional discovery approaches. The company was founded by Annette Friebe, Burckhard Heil, and Claudia Carl in 2007 and is headquartered in Cologne, Germany. | Health Technology |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
quattro research GmbH
quattro research GmbH Miscellaneous Commercial ServicesCommercial Services Quattro Research GmbH is an interdisciplinary team of scientists and IT professionals that provides IT solutions for research and development. The private company is based in Martinsried, Germany. The German company specializes in bioregistration and handles antibodies and other macromolecules. The company also offers products such as the HELM hierarchical editing language for macromolecules and an electronic lab journal. Quattro/CM is their software that helps manage inventory easily. | Commercial Services |
Immunic Research GmbH | |
Brauhaus Germering GmbH | |
Listrax Ug |
- Stock Market
- Insiders
- Daniel Vitt
- Experience